$Improving Management of Relapsed/Refractory Multiple Myeloma$

Improving Management of Relapsed/Refractory Multiple Myeloma

Episodes

Specialty:

All

Year:

All

EP. 1: Introduction to Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 2: Newly Diagnosed Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 3: A Look at the ENDURANCE Trial

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 4: Looking at GRIFFIN Trial Data

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 5: The Role of Transplant in Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 6: Maintenance Therapy in Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 7: Options for Transplant Ineligible Patients in Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 8: Treatment Options in Relapsed/Refractory Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 9: Trials in Relapsed/Refractory Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 10: Targeted Treatment Options in Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

EP. 11: The Future of Multiple Myeloma

ByThomas Martin, MD, University of California San Francisco,Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center

August 10th 2020

Trending on OncLive

Five Under 5: Top Oncology Videos for the Week of 8/31/26

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

The OncFive: Top Oncology Articles for the Week of 8/30